- Home
- RLAY vs RSKD Comparison
RLAY vs RSKD Comparison
Compare RLAY & RSKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- RSKD
- Stock Information
- Founded
- RLAY 2015
- RSKD 2012
- Country
- RLAY United States
- RSKD United States
- Employees
- RLAY N/A
- RSKD N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- RSKD EDP Services
- Sector
- RLAY Health Care
- RSKD Technology
- Exchange
- RLAY Nasdaq
- RSKD Nasdaq
- Market Cap
- RLAY 803.4M
- RSKD 743.4M
- IPO Year
- RLAY 2020
- RSKD 2021
- Fundamental
- Price
- RLAY $5.48
- RSKD $4.73
- Analyst Decision
- RLAY Strong Buy
- RSKD Hold
- Analyst Count
- RLAY 8
- RSKD 7
- Target Price
- RLAY $17.25
- RSKD $5.79
- AVG Volume (30 Days)
- RLAY 1.6M
- RSKD 517.1K
- Earning Date
- RLAY 11-05-2025
- RSKD 11-12-2025
- Dividend Yield
- RLAY N/A
- RSKD N/A
- EPS Growth
- RLAY N/A
- RSKD N/A
- EPS
- RLAY N/A
- RSKD N/A
- Revenue
- RLAY $8,355,000.00
- RSKD $335,825,000.00
- Revenue This Year
- RLAY $27.33
- RSKD $6.27
- Revenue Next Year
- RLAY $8.87
- RSKD $9.63
- P/E Ratio
- RLAY N/A
- RSKD N/A
- Revenue Growth
- RLAY N/A
- RSKD 7.96
- 52 Week Low
- RLAY $1.78
- RSKD $3.94
- 52 Week High
- RLAY $7.07
- RSKD $6.00
- Technical
- Relative Strength Index (RSI)
- RLAY 75.63
- RSKD 50.42
- Support Level
- RLAY $5.17
- RSKD $4.62
- Resistance Level
- RLAY $5.42
- RSKD $4.79
- Average True Range (ATR)
- RLAY 0.29
- RSKD 0.12
- MACD
- RLAY 0.08
- RSKD 0.01
- Stochastic Oscillator
- RLAY 95.97
- RSKD 68.49
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About RSKD Riskified Ltd.
Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.